Quest Diagnostics Inc Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests
Quest Diagnostics Inc (DGX) had Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests of $80.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Equity › Temporary Equity, Including Noncontrolling Interest
us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests · last filed 2026-02-26
- 2025-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $80.00M.
- 2024-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $83.00M.
- 2024-03-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $77.00M.
- 2023-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $76.00M.
| Period end | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests |
|---|---|
| 2025-12-31 | $80.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $83.00M 10-K · filed 2026-02-26 |
| 2024-03-31 | $77.00M 10-Q · filed 2024-04-24 |
| 2023-12-31 | $76.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $76.00M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $77.00M 10-Q · filed 2023-10-25 |
| 2023-03-31 | $77.00M 10-Q · filed 2024-04-24 |
| 2022-12-31 | $77.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $77.00M 10-Q · filed 2023-10-25 |
| 2022-06-30 | $77.00M 10-Q · filed 2023-10-25 |
| 2022-03-31 | $78.00M 10-Q · filed 2023-07-27 |
| 2021-12-31 | $79.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | $79.00M 10-Q · filed 2022-10-21 |
| 2021-06-30 | $78.00M 10-Q · filed 2022-10-21 |
| 2021-03-31 | $79.00M 10-Q · filed 2022-07-22 |
| 2020-12-31 | $82.00M 10-K · filed 2024-02-22 |
| 2020-09-30 | $80.00M 10-Q · filed 2021-10-22 |
| 2020-06-30 | $77.00M 10-Q · filed 2021-10-22 |
| 2020-03-31 | $76.00M 10-Q · filed 2021-07-23 |
| 2019-12-31 | $76.00M 10-K · filed 2023-02-21 |
| 2019-09-30 | $76.00M 10-Q · filed 2020-10-23 |
| 2019-06-30 | $76.00M 10-Q · filed 2020-10-23 |
| 2019-03-31 | $77.00M 10-Q · filed 2020-07-24 |
| 2018-12-31 | $77.00M 10-K · filed 2022-02-28 |
| 2018-09-30 | $77.00M 10-Q · filed 2019-10-23 |
| 2018-06-30 | $76.00M 10-Q · filed 2019-10-23 |
| 2018-03-31 | $77.00M 10-Q · filed 2019-07-24 |
| 2017-12-31 | $80.00M 10-K · filed 2021-02-22 |
| 2017-09-30 | $78.00M 10-Q · filed 2018-10-24 |
| 2017-06-30 | $80.00M 10-Q · filed 2018-07-25 |
| 2017-03-31 | $78.00M 10-Q · filed 2018-04-20 |
| 2016-12-31 | $77.00M 10-K · filed 2020-02-20 |
| 2016-09-30 | $76.00M 10-Q · filed 2017-10-19 |
| 2016-06-30 | $74.00M 10-Q · filed 2017-07-25 |
| 2016-03-31 | $72.00M 10-Q · filed 2017-04-21 |
| 2015-12-31 | $70.00M 10-K · filed 2019-02-21 |
| 2015-09-30 | $69.00M 10-Q · filed 2016-10-21 |
| 2014-12-31 | $0.00 10-K · filed 2018-02-23 |
| 2013-12-31 | $0.00 10-K · filed 2017-02-22 |
| 2012-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |